Clinical Trial: A Trial of HRS-6213 in Healthy Subjects and Patients With Solid Tumors

U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07070349) titled 'A Trial of HRS-6213 in Healthy Subjects and Patients With Solid Tumors' on July 08.

Brief Summary: The study is being conducted to evaluate the safety, radiation dosimetry, pharmacokinetics, and preliminary diagnostic efficacy of HRS-6213.

Study Start Date: July, 2025

Study Type: INTERVENTIONAL

Condition: Patients With Solid Tumors

Intervention: DRUG: HRS-6213

HRS-6213 IV administered as imaging agent for PET scan.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Jiangsu HengRui Medicine Co., Ltd.

Disclaimer: Curated by HT Syndication....